Treatment of the New Era: Long-Term Ticagrelor Monotherapy for the Treatment of Patients with Type 2 Diabetes Mellitus following Percutaneous Coronary Intervention: A Meta-analysis

Fig. 1. Flow diagram representing the study selection

Fig. 2. Forest plot showing the comparison of cardiovascular outcomes between ticagrelor monotherapy and dual antiplatelet therapy following PCI in patients with T2DM

Fig. 3. Forest plot showing the comparison of minor bleeding and TIMI bleeding between ticagrelor monotherapy and dual antiplatelet therapy following PCI in patients with T2DM

Fig. 4. Forest plot showing the comparison of BARC bleeding between ticagrelor monotherapy and dual antiplatelet therapy following PCI in patients with T2DM

Fig. 5. Funnel plot showing publication bias (A)

Fig. 6. Funnel plot showing publication bias (B)